RiverVest Venture Partners
Overview
RiverVest Venture Partners is a prominent venture capital firm specializing in the life sciences sector, focusing on founding and funding early-stage biopharmaceutical and medical device companies across the United States. The firm is dedicated to addressing significant unmet medical needs by developing innovative products that improve patient outcomes. With a strong emphasis on collaboration with entrepreneurs and academic investigators, RiverVest aims to create value for patients, entrepreneurs, and investors through science, strategy, and innovation. Established in 2000, RiverVest has a proven track record of success, having invested in over 55 companies, with 18 successfully sold and eight going public. Notable exits include Allakos (NASDAQ: ALLK), Mirum Pharmaceuticals (NASDAQ: MIRM), and Spruce Biosciences (NASDAQ: SPRB). The firm's disciplined investment approach and hands-on involvement have led to the development of at least 27 commercial products currently treating patients. With offices in St. Louis, San Diego, and Cleveland, RiverVest leverages its extensive network and expertise to identify and support promising life science innovations. The firm's commitment to improving patient lives, supporting entrepreneurs, and delivering strong returns to investors underscores its position as a leader in the venture capital industry.
Investment Focus
- Innovative life science technologies addressing significant unmet medical needs
- Strong management teams with a clear path to commercialization
- Potential for substantial returns on investment
Portfolio Companies
Reach RiverVest Venture Partners directly
Verified work email, phone and LinkedIn for the full team — one spreadsheet, one payment, yours to keep.
Unlock full contacts →Frequently asked questions about RiverVest Venture Partners
What sectors does RiverVest Venture Partners invest in?
RiverVest Venture Partners invests in Biopharmaceutical and Medical Devices & Instruments, and is based in Clayton, Missouri, United States. RiverVest Venture Partners is listed as a venture capital in the ConnectSafely investor database.
What stage does RiverVest Venture Partners invest at?
RiverVest Venture Partners backs companies at Seed, Early Stage, Series A, Series B, Growth and Late Stage.
Which regions does RiverVest Venture Partners invest in?
RiverVest Venture Partners invests across United States.
Who are the partners at RiverVest Venture Partners?
Team members listed for RiverVest Venture Partners include Jay Schmelter (Co-Founder and Managing Director) and Derek Rapp (Managing Director).
What companies has RiverVest Venture Partners invested in?
RiverVest Venture Partners's portfolio includes Mirum Pharmaceuticals, Allakos, Spruce Biosciences, Lokelma, Vfend, Quinsair, Margenza and Lutonix.
How do I contact RiverVest Venture Partners?
RiverVest Venture Partners's contact details — including phone and LinkedIn — are listed in the ConnectSafely investor database, along with its website and the LinkedIn profiles of its partners.
Last updated · Source: ConnectSafely investor database
